title: Analgesic and anti-inflammatory activities of (-)-o benzyl cubebin, a (-)-cubebin derivative, obtained by partial synthesis.
abstract: The anti-inflammatory and antinociceptive effects of the benzylated cubebin derivative, obtained by reaction of (-)-cubebin with benzyl bromide, were investigated using different animal models. The (-)-o-benzyl cubebin showed a low anti-inflammatory effect (16.2%) in relation to cubebin (57%) and indomethacin (77%) in the carrageenin-induced paw edema in rats, but on the other hand it was more effective (80%) than (-)-cubebin (41%) in inhibiting acetic acid-induced writhing in mice, producing dose-response correlation with doses of 10, 20 and 40 mg/kg, respectively. Moreover, this derivative compound did not show activity in both the hot plate and the cell migration test in rats. Overall, the results showed that the benzylation of cubebin were efficient in enhancing only its analgesic activity.
authors.affiliation: Núcleo de Pesquisa em Ciências Exatas e Tecnológicas da Universidade de Franca, Av. Dr. Armando Salles Oliveira, 201, Pq. Universitário, CEP: 14404-600, Franca, SP, Brazil.
authors.forename: H dos S
authors.initials: Hdos S
authors.lastname: Coimbra
authors.forename: V de A
authors.initials: Vde A
authors.lastname: Royo
authors.forename: V A
authors.initials: VA
authors.lastname: de Souza
authors.forename: A C
authors.initials: AC
authors.lastname: Pereira
authors.forename: G H B
authors.initials: GH
authors.lastname: de Souza
authors.forename: R
authors.initials: R
authors.lastname: da Silva
authors.forename: P M
authors.initials: PM
authors.lastname: Donate
authors.forename: M L A
authors.initials: ML
authors.lastname: Silva
authors.forename: W R
authors.initials: WR
authors.lastname: Cunha
authors.forename: J C T
authors.initials: JC
authors.lastname: Carvalho
authors.forename: J K
authors.initials: JK
authors.lastname: Bastos
mesh_terms: D000085:Acetates; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000138:chemical synthesis* / Q000494:pharmacology*; D002351:Carrageenan; D004149:Dioxoles / Q000138:chemical synthesis* / Q000494:pharmacology*; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D005663:Furans / Q000138:chemical synthesis* / Q000494:pharmacology*; D007202:Indicators and Reagents; D008297:Male; D010147:Pain Measurement / Q000187:drug effects; D031701:Piper / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar; D011930:Reaction Time / Q000187:drug effects
chemical_list: D000085:Acetates; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004149:Dioxoles; D005663:Furans; D007202:Indicators and Reagents; C487944:o-benzyl cubebin; D002351:Carrageenan